Brillian Pharma Inc announced that it will issues 21,800,000 series A preference shares for gross proceeds of $28,300,000 on July 7, 2020. The transaction will include participation from Changchun High & New Technology Industry (Group) Inc. (SZSE:000661). Post to the closing, the investor will hold 42.1% in the company.